A randomized phase II/III trial of rosuvastatin with neoadjuvant chemo-radiation in patients with locally advanced rectal cancer

AimStatins have been shown to improve the possibility of a pathological complete response (pCR) in patients with locally advanced rectal cancer when given in combination with neo-adjuvant chemo-radiation (NACTRT) in observational studies. The primary objective of this phase II randomized controlled...

Cijeli opis

Bibliografski detalji

Glavni autori:	Prachi S. Patil, Avanish Saklani, Naveena A. N. Kumar, Ashwin De’Souza, Rahul Krishnatry, Snehal Khanvilkar, Mufaddal Kazi, Reena Engineer, Vikas Ostwal, Anant Ramaswamy, Munita Bal, Priya Ranganathan, Ekta Gupta, Sanjeev Galande
Format:	Artigo
Jezik:	Inglês
Izdano:	Frontiers Media S.A. 2025-03-01
Serija:	Frontiers in Oncology
Teme:	rosuvastatin pathological complete response neoadjuvant chemoradiation rectal cancer drug repurposing
Online pristup:	https://www.frontiersin.org/articles/10.3389/fonc.2025.1450602/full
Oznake:	Dodaj oznaku Bez oznaka, Budi prvi tko označuje ovaj zapis!